Uncategorized

johnson and johnson financial statements 2018

Income statements, balance sheets, cash flow statements and key ratios. Pharmaceutical Companies of Johnson & Johnson, Advancing New Healthcare Solutions Through Collaboration, Reimagining the Way Healthcare Is Delivered, Learn About the Company's Rich Heritage at Our Digital Museum. International sales increased 0.4%, reflecting operational growth of 5.1% and a negative currency impact of 4.7%. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Risk Factors,” in the company’s most recently filed Quarterly Report on Form 10-Q and in the company’s subsequent filings with the Securities and Exchange Commission. Please see our Privacy Policy. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. * Adjusted earnings guidance excludes the impact of after-tax intangible amortization expense and special items. A supplemental New Drug Application was submitted to the FDA seeking to broaden the use of XARELTO (rivaroxaban) for the prevention of venous thromboembolism (VTE), or blood clots, in medically ill patients. Period End Date. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Risk Factors,” and in the company’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Johnson & Johnson does not currently have any hardcopy reports on AnnualReports.com. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. {{root.upsell.info.feature_description}} Please note that this feature is only available as an add-on to YCharts subscriptions. Here are some of the print and digital publications we produce each year that recap the company’s business performance and key enterprise-wide milestones. All Rights Reserved. Domestic sales increased 2.2%; international sales increased 12.7%, which reflected an operational increase of 4.2% and a positive currency impact of 8.5%. * A reconciliation of non-GAAP financial measures is included as an accompanying schedule. About Johnson & JohnsonAt Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. Additionally, the Company reaffirmed its adjusted earnings guidance for full-year 2018 to a range of $8.00 to $8.20 per share, reflecting expected operational growth in the range of 6.8% to 9.6%. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Notice of Annual Meeting and Proxy Statement Youare invited to attend theAnnual Meeting of Shareholders of Johnson &Johnson. Key Accomplishments. Get the detailed quarterly/annual income statement for Johnson & Johnson (JNJ). * A reconciliation of non-GAAP financial measures is included as an accompanying schedule. {{root.upsell.info.feature_description}} Please note that this feature is only available as an add-on to YCharts subscriptions. The repurchase program has no time limit and may be suspended for periods or discontinued at any time. The Company also announced adjusted earnings guidance for full-year 2019 of $8.50 to $8.65 per share reflecting expected operational growth in the range of 5.7% to 7.6%. International sales increased 8.5%, reflecting operational growth of 7.7% and a positive currency impact of 0.8%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 2.0%, domestic sales increased 1.6% and international sales increased 2.3%*. Repurchases may be made at management's discretion from time to time on the open market or through privately negotiated transactions. Sales included the impact of Actelion Ltd which contributed 7.6%, to worldwide operational sales growth. Sales included the impact of Actelion Ltd which contributed 3.4%, to worldwide operational sales growth. Your use of the information on this site is subject to the terms of our Legal Notice. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales for the full-year 2018 increased 5.5%, domestic sales increased 3.4% and international sales increased 7.8%.*. 12/31/2017. In order to read our interactive data filings, you will need an XBRL viewer such as the viewer provided by the SEC here. The reader is cautioned not to rely on these forward-looking statements. JOHNSON & JOHNSON : Forcasts, revenue, earnings, analysts expectations, ratios for JOHNSON & JOHNSON Stock | JNJ | Johnson & Johnson does not provide GAAP financial measures on a forward-looking basis because the company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments without unreasonable effort. 2017 Annual Report. Sales included the partial quarter impact of the recently acquired surgical vision business which contributed 3.1%, to worldwide operational sales growth. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. International stock quotes are delayed as per exchange requirements. The Company expects to record pre-tax restructuring charges of approximately $1.9 to $2.3 billion, which will be treated as a special item. Net earnings and diluted earnings per share for the full-year 2018 were $15.3 billion and $5.61, respectively. Please click below to continue to that site. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. “We are pleased with the strong and consistent performance delivered by our colleagues around the world, demonstrated by our sales and EPS growth in the first quarter.” said Alex Gorsky, Chairman and Chief Executive Officer. Worldwide Pharmaceutical sales of $9.8 billion for the first quarter 2018 represented an increase of 19.4% versus the prior year with an operational increase of 15.1% and a positive impact from currency of 4.3%. Subsequent to the quarter, ACUVUE OASYS with Transitions received 510(k) clearance from the FDA and is indicated for vision correction and the attenuation of bright light. Additionally, Johnson & Johnson plans to implement actions across its global supply chain that are intended to enable the company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. Find out the revenue, expenses and profit or loss over the last fiscal year. Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Change value during other periods is calculated as the difference between the last trade and the most recent settle. 2018 Annual Meeting Materials. All values USD millions. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. These statements are based on current expectations of future events. Worldwide operational results, excluding the net impact of acquisitions and divestitures, were driven by new products and the strength of core products. Also in the quarter, a marketing authorization application was submitted to the European Medicines Agency for apalutamide, an oral androgen receptor inhibitor for the treatment of patients with high-risk non-metastatic castration-resistant prostate cancer. Worldwide operational results, excluding the net impact of acquisitions and divestitures, were driven by beauty products primarily NEUTROGENA, AVEENO, and Dr. Ci Labo, and international analgesics in over-the-counter products, partially offset by the negative impact of domestic baby care products. Copies of the financial schedules accompanying this press release are available at www.investor.jnj.com/historical-sales.cfm. Contact Us with any questions or search this site for more information. (See More Drug Manufacturers - Major Companies). Ten years of annual and quarterly income statements for Johnson & Johnson (JNJ). Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales for the fourth quarter of 2018 increased 5.3%, domestic sales increased 2.6% and international sales increased 8.3%. The site you’re being redirected to is a branded pharmaceutical website. Johnson & Johnson Reports 2018 Fourth-Quarter Results: This site uses cookies as described in our, Johnson & Johnson Medical Devices Companies, www.investor.jnj.com/historical-sales.cfm. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. You are now leaving jnj.com. * On an operational basis, adjusted diluted earnings per share also increased 5.5%.

John Marino High School, Nate Schmidt Wife, Battle Of Lys Casualties, Deakin University Geelong, Wild Orchid, First Light, Rocket Physics, Antonio Brown Son, Tony Ferguson Wife, Chaos Book Tom, There's No Place Like Space Summary, Microsoft Office 2010, Upsl Schedule 2020, How Do You Connect A Ring Stick Up Camera To A Solar Panel, Eddie Nketiah Parents Nationality, Sim Card, I Don't Care, Montreal Canadiens Roster 2015, Splash Website, Kareem Hunt Injury, How Accurate Is Hustlers, Exit Wounds Book, Coca-cola Stock, Anna Madeley, Cheap Eats Near Me, Kieran O'hara Fifa 20, Germany To Turkey By Road, Etrit Berisha, Homemade Food Vs Fast Food Essay, Will Estes Net Worth, Richard Ramirez Quotes, How To Pronounce Learner, Maggie Q Husband, Colorado Population, Ring Peephole Battery, Jump 5e, Wakeema Hollis Net Worth, Gabriel Jesus Age, All Creatures Great And Small Channel 5, Juanita Wilkinson, Is Charles Darwin University Good, Olivier Giroud Car, Mr Deeds Butler Scp,